Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma

被引:208
作者
Ribatti, D
Ennas, MG
Vacca, A
Ferreli, F
Nico, B
Orru, S
Sirigu, P
机构
[1] Univ Bari, Dept Human Anat & Histol, Sch Med, I-70124 Bari, Italy
[2] Univ Bari, Dept Biomed Sci & Human Oncol, Sch Med, I-70124 Bari, Italy
[3] Univ Cagliari, Dept Cytomorphol, Sch Med, Cagliari, Italy
[4] Oncol Hosp, Cagliari, Italy
关键词
angiogenesis; mast cells; melanoma; prognosis; tryptase;
D O I
10.1046/j.1365-2362.2003.01152.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The importance of angiogenesis in melanoma has been controversial and is not homogeneous. Mast cell density (MCD) is highly correlated with the extent of both normal and pathological angiogenesis, such as that in chronic inflammatory diseases and tumours. Methods We evaluated the prognostic significance of tumour microvascular density (MVD) and MCD in 25 advanced melanoma patients after resection and a 4-5-year follow up: 48% of the patients were alive and free of metastases (good prognostic subgroup); 16% had developed regional nodal metastases (intermediate prognostic subgroup); and 36% had died (poor prognostic subgroup). Tissues samples were investigated immunohistochemically to count microvessels and mast cells with an antifactor VIII and an antitryptase antibody, respectively. Results Immunohistological staining showed a higher number of microvessels and mast cells in melanoma lesions of poor prognosis as compared with intermediate prognosis and with good prognosis, respectively. Conclusions These data agree with those showing a close relationship between MCD and angiogenesis during tumour progression and demonstrate, for the first time, a prognostic significance of MCD in human melanoma.
引用
收藏
页码:420 / 425
页数:6
相关论文
共 34 条
[1]  
BARNHILL RL, 1993, AM J PATHOL, V143, P99
[2]  
BARNHILL RL, 1992, LAB INVEST, V67, P331
[3]   Human mast cells stimulate vascular tribe formation - Tryptase is a novel, potent angiogenic factor [J].
Blair, RJ ;
Meng, H ;
Marchese, MJ ;
Ren, SL ;
Schwartz, LB ;
Tonnesen, MG ;
Gruber, BL .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (11) :2691-2700
[4]  
BUSAM KJ, 1995, AM J PATHOL, V147, P1049
[5]   MODEL PREDICTING SURVIVAL IN STAGE-I MELANOMA BASED ON TUMOR PROGRESSION [J].
CLARK, WH ;
ELDER, DE ;
GUERRY, D ;
BRAITMAN, LE ;
TROCK, BJ ;
SCHULTZ, D ;
SYNNESTVEDT, M ;
HALPERN, AC .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24) :1893-1904
[6]  
DETHLEFSEN SM, 1994, INVAS METAST, V14, P395
[7]  
Elias H, 1983, GUIDE PRACTICAL STER, P25
[8]   MOUSE MAST-CELLS AS ANTI-TUMOR EFFECTOR-CELLS [J].
FARRAM, E ;
NELSON, DS .
CELLULAR IMMUNOLOGY, 1980, 55 (02) :294-301
[9]  
FOLLOWFIELD ME, 1991, J PATHOL, V164, P241
[10]   MAST CELL-MEDIATED TUMOR-CELL CYTO-TOXICITY - ROLE OF THE PEROXIDASE SYSTEM [J].
HENDERSON, WR ;
CHI, EY ;
JONG, EC ;
KLEBANOFF, SJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 153 (03) :520-533